Literature DB >> 12503645

Prospective long-term follow-up of patients with pervasive developmental disorders.

Larry Burd1, Jacob Kerbeshian, Alyssia Westerland, Janelle Labine, Amy Barth, Marilyn G Klug, Kay Wagner.   

Abstract

We conducted a 12-year prospective study of children with pervasive developmental disorders from North Dakota. In a prospective longitudinal follow-up study, of 59 patients, we found 52 patients with pervasive developmental disorders (88%). Ten (17%) declined to participate. We collected data on 42 (71%) of the original cohort. Of the 42 subjects, 1 died (1.7%). The other 41 were followed up for 492 person-years. Severity scores for the Diagnostic and Statistical Manual of Mental Disorders-III-Revised (DSM-III-R) declined 20% and for DSM-IV 23%. Global Assessment of Functioning improved 19%, and the average number of comorbidities decreased 45%. Thirty-seven percent of patients improved in all four measures, whereas only 5% improved in only one measure. Pervasive developmental disorders are developmental disorders with a long-term course of limited improvement for most patients. Male subjects demonstrated substantially more variability in improvement but, overall, demonstrated more improvement than female subjects.

Entities:  

Mesh:

Year:  2002        PMID: 12503645     DOI: 10.1177/088307380201700906

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Psychiatric Symptoms in Youth with a History of Autism and Optimal Outcome.

Authors:  Alyssa Orinstein; Katherine E Tyson; Joyce Suh; Eva Troyb; Molly Helt; Michael Rosenthal; Marianne L Barton; Inge-Marie Eigsti; Elizabeth Kelley; Letitia Naigles; Robert T Schultz; Michael C Stevens; Deborah A Fein
Journal:  J Autism Dev Disord       Date:  2015-11

2.  Does gender matter? A one year follow-up of autistic, attention and anxiety symptoms in high-functioning children with autism spectrum disorder.

Authors:  Tamara May; Kim Cornish; Nicole Rinehart
Journal:  J Autism Dev Disord       Date:  2014-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.